CCL18 and sarcoidosis: A much larger study of 102 sarcoidosis patients showed progressively increased levels of CCL-18 and CCL-17 (a CD4 T-cell chemoattractant), but not TNF-α, in BAL of Scadding stage 1–4 patients (n=32/35/23/12, respectively).